Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Touzeau, Cyrille"'
Autor:
Ocio EM; Department of Hematology, University Hospital Marqués de Valdecilla (IDIVAL), University of CantabriaUniversity Hospital Marqués de Valdecilla (IDIVAL), University of Cantabria, Santander, Spain., Nadeem O; Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA., Schjesvold F; Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway., Gay F; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy., Touzeau C; Hematology Department, Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Université d'Angers, Université de Nantes, Nantes, France; Site de Recherche Intégrée sur le Cancer (SIRIC), Imaging and Longitudinal Investigations to Ameliorate Decision-making (ILIAD), Nantes, France; Service d'hématologie Clinique, Centre Hospitalier Universitaire, Place Alexis Ricordeau, Nantes, France., Dimopoulos MA; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Richardson PG; Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA., Mateos MV; Department of Haematology, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), Salamanca, Spain.
Publikováno v:
Expert review of clinical pharmacology [Expert Rev Clin Pharmacol] 2022 Apr; Vol. 15 (4), pp. 371-382. Date of Electronic Publication: 2022 Jun 19.
Autor:
Moreau P; Hematology Clinic, University Hospital Hôtel-Dieu, Nantes, France. Electronic address: philippe.moreau@chu-nantes.fr., Hulin C; Bordeaux University Hospital Center, Bordeaux, France., Perrot A; Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France., Arnulf B; Hematology and Oncology, Hôpital Saint Louis, APHP, Paris, France., Belhadj K; Hôpital Henri Mondor, Creteil, France., Benboubker L; Tours University Hospital, Hôpital de Bretonneau, Tours, France., Béné MC; Hematology Biology, Nantes University Hospital, Nantes, France., Zweegman S; Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Caillon H; Biochemistry Laboratory, Nantes University Hospital, Nantes, France., Caillot D; Dijon University Hospital, Hôpital du Bocage, Dijon, France., Corre J; Unité de Genomique du Myélome, IUC-T Oncopole, Toulouse, France., Delforge M; Department of Hematology, University Hospital Leuven, Leuven, Belgium., Dejoie T; Biochemistry Laboratory, Nantes University Hospital, Nantes, France., Doyen C; Université Catholique de Louvain, CHU UCL Namur, Yvoir, Belgium., Facon T; Service des Maladies du Sang, Hôpital Claude Huriez, Lille, France., Sonntag C; University Hospital, Hôpital Hautepierre, Strasbourg, France., Fontan J; University Hospital Jean Minjoz, Besancon, France., Mohty M; Hematology and Cellular Therapy Department of Saint-Antoine Hospital, Sorbonne University, Paris, France., Jie KS; Zuyderland MC, Sittard, Netherlands., Karlin L; Lyon University Hospital, Hematology Centre Hospitalier Lyon-Sud, Pierre-Bénite, France., Kuhnowski F; Institut Curie Paris, Paris, France., Lambert J; Hôpital Saint-Louis, Paris, France., Leleu X; Poitiers University Hospital, CHU la Milétrie, Poitiers, France., Macro M; Caen University Hospital, Caen, France., Orsini-Piocelle F; Centre Hospitalier Annecy Genevois, Pringy, France., Roussel M; CHU Dupuytren, Limoges, France., Stoppa AM; Institut Paoli Calmettes, Marseille, France., van de Donk NWCJ; Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Wuillème S; Hematology Biology, Nantes University Hospital, Nantes, France., Broijl A; Erasmus MC Cancer Institute, Rotterdam, Netherlands., Touzeau C; Hematology Clinic, University Hospital Hôtel-Dieu, Nantes, France., Tiab M; Centre Hospitalier Départemental Vendée, La Roche sur Yon, France., Marolleau JP; Hematology Clinic, Amiens University Hospital, Amiens, France., Meuleman N; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Vekemans MC; Université Catholique de Louvain, Cliniques Universitaires Saint-Luc, Brussels, Belgium., Westerman M; Northwest Clinics, Alkmaar, Netherlands., Klein SK; Meander Medical Centre, Amersfoort, Netherlands., Levin MD; Albert Schweitzer Ziekenhuis, Dordrecht, Netherlands., Offner F; University Hospital Ghent, Ghent, Belgium., Escoffre-Barbe M; Rennes University Hospital, Hôpital de Pontchaillou, Rennes, France., Eveillard JR; Brest University Hospital, Hôpital A Morvan, Brest, France., Garidi R; Saint-Quentin Hospital Center, Saint Quentin, France., Ahmadi T; Genmab, Princeton, NJ, USA., Krevvata M; Janssen Research & Development, Spring House, PA, USA., Zhang K; Janssen Research & Development, La Jolla, CA, USA., de Boer C; Janssen Research & Development, LLC, Leiden, Netherlands., Vara S; Janssen Research & Development, High Wycombe, UK., Kampfenkel T; Janssen Research & Development, LLC, Leiden, Netherlands., Vanquickelberghe V; Janssen Research & Development, Beerse, Belgium., Vermeulen J; Janssen Research & Development, LLC, Leiden, Netherlands., Avet-Loiseau H; Unité de Genomique du Myélome, IUC-T Oncopole, Toulouse, France., Sonneveld P; Erasmus MC Cancer Institute, Rotterdam, Netherlands.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2021 Oct; Vol. 22 (10), pp. 1378-1390. Date of Electronic Publication: 2021 Sep 13.
Autor:
Richardson PG; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Oriol A; Institut Català d'Oncologia and Josep Carreras Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain., Larocca A; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Torino, Italy., Bladé J; Hematology Department, IDIBAPS, Hospital Clinic, Barcelona, Spain., Cavo M; Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy., Rodriguez-Otero P; Clínica Universidad de Navarra, Pamplona, Spain., Leleu X; CHU de Poitiers, Poitiers, France., Nadeem O; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Hiemenz JW; Division of Hematology-Oncology, Department of Medicine, University of Florida, Gainesville, FL., Hassoun H; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Touzeau C; Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Université d'Angers, Université de Nantes, Nantes, France.; Site de Recherche Intégrée sur le Cancer (SIRIC), Imaging and Longitudinal Investigations to Ameliorate Decision-making (ILIAD), Nantes, France.; Service d'hématologie Clinique, Centre Hospitalier Universitaire, Place Alexis Ricordeau, Nantes, France., Alegre A; Hospital Universitario La Princesa and Hospital Universitario Quironsalud, Madrid, Spain., Paner A; Rush University Medical Center, Chicago, IL., Maisel C; Baylor Scott & White Charles A. Sammons Cancer Center, Dallas, TX., Mazumder A; The Oncology Institute of Hope and Innovation, Glendale, CA., Raptis A; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA., Moreb JS; Novant Health Hematology, Novant Health Forsyth Medical Center, Winston-Salem, NC., Anderson KC; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Laubach JP; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Thuresson S; Oncopeptides AB, Stockholm, Sweden., Thuresson M; Oncopeptides AB, Stockholm, Sweden., Byrne C; Oncopeptides AB, Stockholm, Sweden., Harmenberg J; Oncopeptides AB, Stockholm, Sweden., Bakker NA; Oncopeptides AB, Stockholm, Sweden., Mateos MV; Hospital Clínico Universitario de Salamanca/IBSAL/CIC, Salamanca, Spain.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Mar 01; Vol. 39 (7), pp. 757-767. Date of Electronic Publication: 2020 Dec 09.
Autor:
Sureda A; Institut Català d'Oncologia, Hospital Duran i Reynals, Barcelona, Spain. asureda@iconcologia.net., Chabannon C; Institut Paoli-Calmettes, Marseille, France., Masszi T; Semmelweis University, Budapest, Hungary., Pohlreich D; Charles University Hospital, Prague, Czech Republic., Scheid C; University of Cologne, Cologne, Germany., Thieblemont C; APHP, Hôpital Saint-Louis, Service d'hémato-oncologie, Université Paris Diderot - and Université Sorbonne Paris Cité, Paris, France., Wahlin BE; Karolinska University Hospital, Stockholm, Sweden., Sakellari I; George Papanicolaou General Hospital, Thessaloniki, Greece., Russell N; Nottingham University Hospital, Nottingham, UK., Janikova A; University Hospital Brno, Brno, Czech Republic., Dabrowska-Iwanicka A; Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland., Touzeau C; CHU Nantes, Nantes, France., Esquirol A; Hospital de la Santa Creu Sant Pau, Barcelona, Spain., Jantunen E; University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland., van der Werf S; EBMT Data Office, Leiden, Netherlands., Bosman P; EBMT Data Office, Leiden, Netherlands., Boumendil A; EBMT Statistical Unit, Paris, France., Liu Q; Sanofi Genzyme, Cambridge, MA, USA., Celanovic M; Sanofi Genzyme, Cambridge, MA, USA., Montoto S; St Bartholomew's Hospital, Barts Health NHS Trust, London, UK., Dreger P; University of Heidelberg, Heidelberg, Germany.
Publikováno v:
Bone marrow transplantation [Bone Marrow Transplant] 2020 Mar; Vol. 55 (3), pp. 613-622. Date of Electronic Publication: 2019 Sep 30.